{{Rsnum
|rsid=1678542
|Gene=KIF5A
|Chromosome=12
|position=57574932
|Orientation=minus
|GMAF=0.4793
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=KIF5A
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 11.5 | 55.8 | 32.7
| HCB | 62.8 | 30.7 | 6.6
| JPT | 58.4 | 38.9 | 2.7
| YRI | 17.1 | 53.4 | 29.5
| ASW | 21.1 | 50.9 | 28.1
| CHB | 62.8 | 30.7 | 6.6
| CHD | 51.4 | 45.0 | 3.7
| GIH | 32.7 | 48.5 | 18.8
| LWK | 13.6 | 56.4 | 30.0
| MEX | 20.7 | 51.7 | 27.6
| MKK | 5.8 | 34.0 | 60.3
| TSI | 8.9 | 52.5 | 38.6
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs1678542
|PubMedID=18794853
|Condition=Rheumatoid arthritis
|Gene=KIF5A-PIP4K2C
|Risk Allele=C
|pValue=9.00E-008
|OR=1.12
|95CI=
|OA=1
}}

{{omim
|desc=RHEUMATOID ARTHRITIS; RA
|id=180300
|rsnum=1678542
}}

{{PharmGKB
|RSID=rs1678542
|Name_s=
|Gene_s=KIF5A
|Feature=
|Evidence=PubMed ID:18794853; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS Results: Common variants at CD40 and other loci confer risk of rheumatoid arthritis (Initial Sample Size: 3,393 cases, 12,460 controls; Replication Sample Size: 3,929 cases, 5,807 controls; Risk Allele: rs1678542-C). This variant is associated with Rheumatoid arthritis.
|Drugs=
|Drug Classes=
|Diseases=Arthritis, Rheumatoid
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356416
}}

{{PMID Auto
|PMID=19956108
|Title=Analysis of 55 autoimmune disease and type II diabetes loci: further confirmation of chromosomes 4q27, 12q13.2 and 12q24.13 as type I diabetes loci, and support for a new locus, 12q13.3-q14.1
|OA=1
}}

{{PMID Auto
|PMID=20508602
|Title=The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis
}}
{{PMID Auto
|PMID=20498205
|Title=Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers
|OA=1
}}

{{PharmGKB
|RSID=rs1678542
|Name_s=
|Gene_s=KIF5A
|Feature=
|Evidence=PubMed ID:18794857
|Annotation=This SNP located on chromosomes 12q13 is associated with susceptibility to rheumatoid arthritis in a validation study of 4,106 individuals with rheumatoid arthritis and an expanded reference group of 11,238 subjects.
|Drugs=
|Drug Classes=
|Diseases=Arthritis, Rheumatoid
|Curation Level=Curated
|PharmGKB Accession ID=PA162355650
}}

{{PMID Auto
|PMID=19674979
|Title=Overlap of disease susceptibility loci for rheumatoid arthritis and juvenile idiopathic arthritis.
|OA=1
}}

{{PMID Auto
|PMID=20439292
|Title=Genetic variants in the prediction of rheumatoid arthritis.
}}

{{PMID Auto
|PMID=20444755
|Title=Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1678542
|overall_frequency_n=59
|overall_frequency_d=128
|overall_frequency=0.460938
|n_genomes=36
|n_genomes_annotated=0
|n_haplomes=46
|n_articles=1
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{PMID Auto
|PMID=23378462
|Title=Replication of European Rheumatoid Arthritis Loci in a Pakistani Population
}}

{{PMID Auto
|PMID=22328738
|Title=Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}